Basic HTML Version
Division of Vascular and Endovascular Surgery
May 6 2011
•
FDA interpreted the CREST Data
•
Expanded the indication for Carotid Stenting to include
standard risk patients
•
Emphasized the need for long-term follow up
•
Necessary use of embolic protection
•
As a condition of the approval, stent manufacturer will
need to conduct a post-approval study for 3 years.
•
Also need to evaluate how patients >80 respond to
stenting
Presentation Title Goes Here
12